Advertisement

Randomized Trials of Estrogen for Memory and Dementia

  • Victor W. Henderson
Part of the Medical Science Symposia Series book series (MSSS, volume 17)

Abstract

It is well-documented that memory and other cognitive skills decline with age, beginning in midlife and progressing thereafter [1]. Among the different kinds of memory affected by aging, long-term memory [2] is the most important. Long-term memory is often evaluated by delayed recall tasks, in which new information is presented for learning, followed some minutes later by the conscious recall of this information. In contrast, short-term memory is assessed by recall several seconds after new information is presented. Separate distinction is sometimes made between memory for verbal information and memory for information not easily described by words (for example, a visual pattern).

Keywords

Postmenopausal Woman Verbal Memory Estrogen Replacement Therapy Estrogen Effect Paired Associate Learning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Storandt M. Longitudinal studies of aging and age-associated dementias. In: Boller F, Grafman J, editors. Handbook of Neuropsychology, vol. 4. New York: Elsevier, 1991.Google Scholar
  2. 2.
    Squire LT, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253: 1380–86.PubMedCrossRefGoogle Scholar
  3. 3.
    Ritchie K, Kildea D. Is senile dementia “age-related” or “ageing-related”? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 1997; 346:931–34.CrossRefGoogle Scholar
  4. 4.
    van Duijn CM. Epidemiology of the dementias: Recent developments and new approaches. J Neurol Neurosurg Psychiatry 1996; 60:478–88.PubMedCrossRefGoogle Scholar
  5. 5.
    Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987; 76:465–79.PubMedCrossRefGoogle Scholar
  6. 6.
    Bretsky PM, Buckwalter JG, Seeman TE, et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999; 13:216–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Fairer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 1997; 278:1349–56.CrossRefGoogle Scholar
  8. 8.
    Henderson VW. Hormone therapy and the brain: A clinical perspective on the role of estrogen. New York: Parthenon Publishing, 2000.Google Scholar
  9. 9.
    Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 1997; 388:507–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Wong M, Thompson TL, Moss RL. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit RevNeurobiol 1996; 10:189–203.Google Scholar
  11. 11.
    Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague Dawley rats. Brain Res 1994; 644:305–12.PubMedCrossRefGoogle Scholar
  12. 12.
    Fader AJ, Hendricson AW, Dohanich GP. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiol Learn Memory 1998; 69:225–40.CrossRefGoogle Scholar
  13. 13.
    Tanapat P, Hastings NB, Reeves AJ, Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci 1999; 19:5792–5801.PubMedGoogle Scholar
  14. 14.
    Foy MR, Henderson VW, Berger TW, Thompson RF. Estrogen and neural plasticity. Curr Dir Psychol Sci 2000; 9:148–52.CrossRefGoogle Scholar
  15. 15.
    Luine V. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89:484–90.PubMedCrossRefGoogle Scholar
  16. 16.
    Petanceska SS, Nagy G, Frail D, Gandy S. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain. Neurology 2000; 54:2212–17.PubMedCrossRefGoogle Scholar
  17. 17.
    Portin R, Polo-Kantola P, Polo O, et al. Serum estrogen level, attention, memory and other cognitive functions in middle-aged women. Climacteric 1999; 2:115–23.PubMedCrossRefGoogle Scholar
  18. 18.
    Barrett-Connor E, Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc 1999; 47:1289–93.PubMedGoogle Scholar
  19. 19.
    Drake EB, Henderson VW, Stanczyk FZ, et al. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 2000; 54:599–603.PubMedCrossRefGoogle Scholar
  20. 20.
    Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994; 83:979–83.PubMedCrossRefGoogle Scholar
  21. 21.
    Jacobs DM, Tang MX, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998; 50:368–73.PubMedCrossRefGoogle Scholar
  22. 22.
    Maki PM, Zonderman AB, Resnick SM. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 2001; 158:227–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Schmidt R, Fazekas F, Reinhart B, et al. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc 1996; 44:1307–13.PubMedGoogle Scholar
  25. 25.
    Szklo M, Cerhan J, Diez-Roux AV, et al. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 1996; 144:1048–57.PubMedCrossRefGoogle Scholar
  26. 26.
    Hogervorst E, Boshuisen M, Riedel W, et al. The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology 1999; 24:43–68.PubMedCrossRefGoogle Scholar
  27. 27.
    Haskell SG, Richardson ED, Horwitz RI. The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature. J Clin Epidemiol 1997; 50: 1249–64.PubMedCrossRefGoogle Scholar
  28. 28.
    Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women. JAMA 1998; 279:688–95.PubMedCrossRefGoogle Scholar
  29. 29.
    Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: A meta- analysis. Neuroscience 2000; 101:485–512.PubMedCrossRefGoogle Scholar
  30. 30.
    Vanhulle G, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. Consensus on menopause research: A summary of international opinion. Baltimore: University Park Press, 1976:94–99.Google Scholar
  31. 31.
    Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988; 13:345–57.PubMedCrossRefGoogle Scholar
  32. 32.
    Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17:485–95.PubMedCrossRefGoogle Scholar
  33. 33.
    Sherwin BB, Tulandi T. “Add back” estrogen reverses cognitive deficits induced by a gonadotropin releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996; 81:2545–49.PubMedCrossRefGoogle Scholar
  34. 34.
    Polo-Kantola P, Portin R, Polo O, et al. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998; 91:459–66.PubMedCrossRefGoogle Scholar
  35. 35.
    Wolf OT, Kudielka MB, Hellhammer DH, et al. Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: Verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology 1999; 24:727–41.PubMedCrossRefGoogle Scholar
  36. 36.
    Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 2000; 149:129–39.PubMedCrossRefGoogle Scholar
  37. 37.
    Binder EF, Schechtman KB, Birge SJ, et al. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 2001; 38:137–46.PubMedCrossRefGoogle Scholar
  38. 38.
    Cherry B J, Buckwalter JG, Henderson V W. Better preservation of memory span relative to supraspan immediate recall in Alzheimer’s disease. Neuropsychologia; in press.Google Scholar
  39. 39.
    Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replacement therapy in older women: Comparisons between Alzheimer’s disease cases and nondemented control subjects. Arch Neurol 1994; 51:896–900.PubMedCrossRefGoogle Scholar
  40. 40.
    Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer’s disease. Arch Intern Med 1996; 156:2213–17.PubMedCrossRefGoogle Scholar
  41. 41.
    Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 1996; 348:429–32.PubMedCrossRefGoogle Scholar
  42. 42.
    Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology 1997; 48:1517–21.PubMedCrossRefGoogle Scholar
  43. 43.
    Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen replacement therapy and Alzheimer’s disease in the Italian Longitudinal Study on Aging. Neurology 1998; 50:996–1002.PubMedCrossRefGoogle Scholar
  44. 44.
    Slooter AJ, Bronzova J, Witteman JC, et al. Estrogen use and early onset Alzheimer’s disease: A population-based study. J Neurol Neurosurg Psychiatry 1999; 67:779–81.PubMedCrossRefGoogle Scholar
  45. 45.
    Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer s disease: A population-based case-control study. Am J Epidemiol 1994; 140:262–67.PubMedGoogle Scholar
  46. 46.
    Seshadri S, Zomberg GL, Derby LE, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s disease. Arch Neurol 2001; 58:435–40.PubMedCrossRefGoogle Scholar
  47. 47.
    Vickers MR. The MRC long-term randomised control trial of hormone replacement therapy: background, design and objectives. J Br Menopause Soc 1996; 2(3):9–13.Google Scholar
  48. 48.
    Shumaker SA, Reboussin BA, Espeland MA, et al. The Women’s Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Controlled Clin Trials 1998; 19:604–21.PubMedCrossRefGoogle Scholar
  49. 49.
    Honjo H, Ogino Y, Tanaka K, et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia Alzheimer’s type: A placebo controlled double blind study. J Jpn Menopause Soc 1993; 1:167–71.Google Scholar
  50. 50.
    Asthana S, Craft S, Baker LD, et al. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: Results of a placebocontrolled, double-blind, pilot study. Psychoneuroendocrinology 1999; 24:657–77.PubMedCrossRefGoogle Scholar
  51. 51.
    Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000; 54:295–301.PubMedCrossRefGoogle Scholar
  52. 52.
    Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. JAMA 2000; 283:1007–15.PubMedCrossRefGoogle Scholar
  53. 53.
    Wang PN, Liao SQ, Liu RS, et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study. Neurology 2000; 54:2061–66.PubMedCrossRefGoogle Scholar
  54. 54.
    Asthana S, Baker LD, Craft S, et al. High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology 2001; 57:605–12.PubMedCrossRefGoogle Scholar
  55. 55.
    Henderson VW, Watt L, Buckwalter JG. Cognitive skills associated with estrogen replacement in women with Alzheimer’s disease. Psychoneuroendocrinology 1996;21:421–30.PubMedCrossRefGoogle Scholar
  56. 56.
    Henderson VW. Estrogen replacement therapy for the prevention and treatment of Alzheimer’s disease. CNS Drugs 1997; 8:343–51.CrossRefGoogle Scholar
  57. 57.
    Fillit H. Estrogens in the pathogenesis and treatment of Alzheimer’s disease in postmenopausal women. Ann NY Acad Sci 1994; 743:233–38.PubMedCrossRefGoogle Scholar
  58. 58.
    Birge SJ. The role of estrogen in the treatment of Alzheimer’s disease. Neurology 1997; 48 (Suppl.7):S36–S41.PubMedCrossRefGoogle Scholar
  59. 59.
    Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer’s disease. Neurology 1996; 46: 1580–84.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Victor W. Henderson

There are no affiliations available

Personalised recommendations